Overview
Portfolio
More
PXN Ventures
Manchester, United Kingdom
Legacy more-than-money support model for Northern UK founders, now merged into PXN Ventures.
Portfolio
1+
Employees
15+
Founded
N/A
AUM
≈ $393.7M
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
Northern IrelandNorth of EnglandScotland
Fund details
Funds
Fund
Vintage 2022 • $19.1M
Sources
PXN Ventures
Legacy more-than-money support model for Northern UK founders, now merged into PXN Ventures.
Portfolio
1+
Employees
15+
Founded
N/A
AUM
≈ $393.7M
Funds
Fund · Vintage 2022 • $19.1M
Stages
No stages listed
Industries
No industries listedGeographic scope
Northern IrelandNorth of EnglandScotland
Sources
Showing 1 of 1 matched portfolio company
Imperagen has developed a fully automated platform that integrates AI-driven hotspot identification, precision DNA editing, and laboratory automation to enhance enzyme engineering. This technology significantly reduces the time and resources required for enzyme development, enabling rapid creation and optimization of enzyme variants across diverse applications.
Funding: $10.8M
Rough estimate of the amount of funding raised
IQ CapitalNorthern Gritstone
IQ CapitalNorthern Gritstone
Funding: $10.8M
Rough estimate of the amount of funding raised